Bio-Techne Corporation (TECH) DCF Valuation

Bio-Techne Corporation (TECH) DCF Valuation
  • Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • Professional Design: Trusted, Industry-Standard Templates
  • Pre-Built For Quick And Efficient Use
  • No Expertise Is Needed; Easy To Follow

Bio-Techne Corporation (TECH) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you’re an investor or analyst, this (TECH) DCF Calculator is your go-to resource for accurate valuation. Loaded with real data from Bio-Techne Corporation, you can adjust forecasts and view the effects in real-time.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 738.7 931.0 1,105.6 1,136.7 1,159.1 1,302.7 1,464.1 1,645.6 1,849.5 2,078.7
Revenue Growth, % 0 26.04 18.75 2.81 1.97 12.39 12.39 12.39 12.39 12.39
EBITDA 373.9 258.5 420.1 460.6 310.4 478.5 537.8 604.5 679.4 763.6
EBITDA, % 50.62 27.76 38 40.52 26.78 36.73 36.73 36.73 36.73 36.73
Depreciation 82.7 87.7 101.1 107.2 111.7 127.2 143.0 160.7 180.7 203.0
Depreciation, % 11.2 9.42 9.14 9.43 9.64 9.77 9.77 9.77 9.77 9.77
EBIT 291.2 170.7 319.0 353.3 198.7 351.3 394.8 443.8 498.7 560.6
EBIT, % 39.42 18.34 28.86 31.08 17.14 26.97 26.97 26.97 26.97 26.97
Total Cash 270.9 231.6 247.0 204.3 152.9 299.7 336.9 378.6 425.6 478.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 122.5 145.4 194.5 218.5 241.4
Account Receivables, % 16.59 15.62 17.6 19.22 20.83
Inventories 103.2 116.7 141.1 171.6 179.7 182.0 204.6 230.0 258.5 290.5
Inventories, % 13.96 12.54 12.76 15.1 15.51 13.97 13.97 13.97 13.97 13.97
Accounts Payable 23.1 29.4 33.9 25.7 38.0 38.8 43.6 49.0 55.0 61.9
Accounts Payable, % 3.13 3.16 3.06 2.26 3.28 2.98 2.98 2.98 2.98 2.98
Capital Expenditure -51.7 -44.3 -44.9 -38.2 -62.9 -64.1 -72.1 -81.0 -91.0 -102.3
Capital Expenditure, % -7 -4.76 -4.06 -3.36 -5.42 -4.92 -4.92 -4.92 -4.92 -4.92
Tax Rate, % 9.47 9.47 9.47 9.47 9.47 9.47 9.47 9.47 9.47 9.47
EBITAT 241.5 161.8 288.0 297.6 179.8 311.1 349.6 392.9 441.6 496.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 69.9 175.1 275.1 304.0 210.0 380.0 373.8 420.1 472.1 530.7
WACC, % 10.25 10.27 10.26 10.25 10.26 10.26 10.26 10.26 10.26 10.26
PV UFCF
SUM PV UFCF 1,610.7
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 552
Terminal Value 8,821
Present Terminal Value 5,414
Enterprise Value 7,025
Net Debt 268
Equity Value 6,757
Diluted Shares Outstanding, MM 161
Equity Value Per Share 42.03

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real Bio-Techne Corporation (TECH) financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effects of your inputs on Bio-Techne Corporation’s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Customizable Forecast Inputs: Adjust essential metrics such as revenue growth, EBITDA %, and capital investments.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other key metrics.
  • High-Precision Accuracy: Leverages Bio-Techne’s actual financial data for realistic valuation results.
  • Effortless Scenario Analysis: Easily evaluate various assumptions and analyze different outcomes.
  • Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.

How It Works

  • Download: Get the pre-built Excel file containing Bio-Techne Corporation’s (TECH) financial data.
  • Customize: Modify forecasts such as revenue growth, EBITDA %, and WACC to fit your analysis.
  • Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and instantly compare the results.
  • Make Decisions: Leverage the valuation findings to inform your investment approach.

Why Choose Bio-Techne Corporation (TECH)?

  • Innovative Solutions: Access cutting-edge technologies and products tailored for life sciences.
  • Commitment to Quality: High standards in research and development ensure reliable results.
  • Extensive Product Range: A diverse portfolio meets various needs across multiple disciplines.
  • Expert Support: Dedicated customer service and technical assistance available for all users.
  • Recognized Leader: Trusted by researchers and professionals in the scientific community.

Who Should Use This Product?

  • Investors: Accurately estimate Bio-Techne Corporation’s (TECH) fair value before making investment decisions.
  • CFOs: Leverage a professional-grade DCF model for financial reporting and analysis related to Bio-Techne Corporation (TECH).
  • Consultants: Quickly adapt the template for valuation reports tailored to Bio-Techne Corporation (TECH) clients.
  • Entrepreneurs: Gain insights into financial modeling practices utilized by leading biotech firms like Bio-Techne Corporation (TECH).
  • Educators: Use it as a teaching tool to demonstrate valuation methodologies relevant to Bio-Techne Corporation (TECH).

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Bio-Techne Corporation (TECH) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Bio-Techne Corporation (TECH).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.